Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103172645A details a scalable route from artemisinic acid. Offers high yield and purity for API intermediates. Ideal for pharmaceutical supply chains.
Patent CN1314336A details a novel two-component resolution method for high-purity (S)-(+)-ibuprofen, offering significant cost and time advantages for pharmaceutical manufacturing supply chains.
Patent CN119528922B details chiral synthesis for galantamine impurity. Offers high purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel synthesis route for oxadiazole compound offers high purity and simplified purification for reliable pharmaceutical intermediate supply chains globally.
Patent CN116874392A enables high-yield route for Finerenone intermediate. Reduces heavy metal use and enhances supply chain stability for pharmaceutical manufacturers globally.
Novel toluene-ethanol solvent system enhances yield and purity for steroid hormone intermediates, offering significant supply chain and cost advantages for pharmaceutical manufacturers.
Novel Salen Co catalysis method reduces costs and improves supply chain reliability for high-purity rosuvastatin calcium intermediate manufacturing globally.
Patent CN104326984A details solvent-free edaravone synthesis ensuring high purity and reduced impurities for reliable pharmaceutical intermediate supply chains.
Patent CN103880830A details a novel Azilsartan synthesis avoiding unstable intermediates. This report analyzes cost reduction and supply chain reliability for API manufacturers.
Patent CN101838816A details a green electrochemical route for 5,5'-dihydroxy-4,4'-bispyrazoles, offering safer scaling and cost reduction in pharmaceutical intermediate manufacturing.
Discover a robust biocatalytic route for (2S, 3R)-methyl phenyl glycidate using Enterobacter sp. ECU 1107, offering superior purity and scalable manufacturing for taxol synthesis.
Novel purification method for esomeprazole sodium reduces solvent use and impurities. Enhances supply chain reliability and cost efficiency for pharmaceutical manufacturing partners globally.
Patent CN101463063B reveals a green Lewis acid/water method for amino steroid intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN109456339A reveals a novel Cefuroxime Sodium route avoiding acyl chlorides. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Discover the novel 2-step synthesis of SCH-79797 via CN113620961B. This method eliminates toxic reagents, offering significant cost reduction and high purity for API manufacturing.
Novel synthesis route for PI3K inhibitor intermediates ensures high purity and scalable production for global pharmaceutical supply chains and cost efficiency in manufacturing.
Novel ketoreductase method for ezetimibe intermediate. Reduces cost, improves purity. Reliable supplier for pharma intermediates.
Patent CN119707988A reveals green photocatalytic route for antiviral quinazolinones offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106397449A reveals metal-free synthesis for high-purity pharmaceutical intermediates offering supply chain stability and cost reduction in manufacturing processes.
Patent CN106397449A details metal-free synthesis for furoisoquinoline derivatives ensuring high purity and supply chain stability for pharmaceutical intermediate manufacturing.